Antibody-mediated rejection due to anti-HLA-DQ antibody after pregnancy and delivery in a female kidney transplant recipient
- PMID: 29968405
- DOI: 10.1111/nep.13279
Antibody-mediated rejection due to anti-HLA-DQ antibody after pregnancy and delivery in a female kidney transplant recipient
Abstract
Herein, we report a case of antibody-mediated rejection (ABMR) due to anti-HLA-DQ antibody after pregnancy and delivery in a female kidney transplant recipient. A 34-year-old female recipient was admitted at 2 years after delivery for an examination of an elevated serum creatinine (S-Cr) level. The patient had received a living kidney transplantation from her mother at 22 years of age, and her kidney graft function was almost stable. The episode biopsy showed peritubular capillaritis and transplant capillaropathy with C4d immunoreactivity in the peritubular capillaries. Additional examination revealed expression of a donor-specific antibody (DSA) against HLA-DQ5, leading to the diagnosis of chronic active ABMR. Intravenous immunoglobulin, plasma exchange, and rituximab were administered, and her S-Cr level was maintained stable. This case demonstrates a possible relationship between pregnancy/delivery and development of ABMR due to a de novo DSA in a female kidney transplant recipient.
Keywords: anti-HLA-DQ antibody; antibody-mediated rejection; donor-specific antibody; living related kidney transplantation; pregnancy and delivery.
© 2018 Asian Pacific Society of Nephrology.
Similar articles
-
A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient.Nephrology (Carlton). 2015 Jul;20 Suppl 2:81-5. doi: 10.1111/nep.12453. Nephrology (Carlton). 2015. PMID: 26031594
-
Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies.Nephrology (Carlton). 2015 Jul;20 Suppl 2:75-8. doi: 10.1111/nep.12467. Nephrology (Carlton). 2015. PMID: 26031592 Review.
-
Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.Clin Transpl. 2014:223-30. Clin Transpl. 2014. PMID: 26281149
-
Subclinical antibody-mediated rejection due to anti-human-leukocyte-antigen-DR53 antibody accompanied by plasma cell-rich acute rejection in a patient with cadaveric kidney transplantation.Nephrology (Carlton). 2016 Jul;21 Suppl 1:31-4. doi: 10.1111/nep.12772. Nephrology (Carlton). 2016. PMID: 26971538
-
Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.Curr Opin Organ Transplant. 2010 Feb;15(1):42-8. doi: 10.1097/MOT.0b013e3283352a50. Curr Opin Organ Transplant. 2010. PMID: 20009933 Review.
Cited by
-
Acute kidney injury during pregnancy in kidney transplant recipients.Clin Transplant. 2022 May;36(5):e14668. doi: 10.1111/ctr.14668. Epub 2022 Apr 17. Clin Transplant. 2022. PMID: 35396888 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials